Missouri Trust & Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Missouri Trust & Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.5K	Hold	1,030	–	–	0.02%	209
2025 Q4	$55.6K	Hold	1,030	–	–	0.02%	221
2025 Q3	$46.5K	Hold	1,030	–	–	0.01%	236
2025 Q2	$47.7K	Hold	1,030	–	–	0.02%	221
2025 Q1	$62.8K	Hold	1,030	–	–	0.02%	190
2024 Q4	$58.3K	Buy	1,030 +800	+348%	+$44.7K	0.02%	199
2024 Q3	$11.9K	Buy	230 +100	+77%	+$4.69K	﹤0.01%	286
2024 Q2	$5.4K	Sell	130 -3,305	-96%	-$148K	﹤0.01%	327
2024 Q1	$186K	Hold	3,435	–	–	0.07%	127
2023 Q4	$176K	Hold	3,435	–	–	0.07%	124
2023 Q3	$199K	Sell	3,435 -37	-1%	-$2.27K	0.09%	117
2023 Q2	$222K	Sell	3,472 -12	-0.3%	-$805	0.13%	115
2023 Q1	$241K	Buy	3,484 +600	+21%	+$42.3K	0.16%	102
2022 Q4	$208K	Hold	2,884	–	–	0.12%	104
2022 Q3	$205K	Buy	2,884 +12	+0.4%	+$870	0.13%	100
2022 Q2	$221K	Hold	2,872	–	–	0.14%	98
2022 Q1	$210K	Sell	2,872 -200	-7%	-$13.4K	0.12%	106
2021 Q4	$192K	Buy	+3,072	New	+$180K	0.11%	112

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Missouri Trust & Investment Company's BMY Position: Q1 2026 in Review

Missouri Trust & Investment Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 1,030 shares worth $62.5K. The position accounts for 0.02% of the portfolio, ranked #209.

Missouri Trust & Investment Company first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $241K in Q1 2023. 2,527 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Missouri Trust & Investment Company held 1,030 shares of Bristol-Myers Squibb worth $62.5K as of Q1 2026.
Missouri Trust & Investment Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.02% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #209 holding.
Missouri Trust & Investment Company first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
Missouri Trust & Investment Company's Bristol-Myers Squibb position peaked at $241K in Q1 2023.
2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.